These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 25366967)
1. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation. Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967 [TBL] [Abstract][Full Text] [Related]
2. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells. Ishikawa R; Kajikawa M; Ishido S Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470 [TBL] [Abstract][Full Text] [Related]
3. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis. Pennell LM; Fish EN Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573 [TBL] [Abstract][Full Text] [Related]
4. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
5. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability. Periasamy P; O'Neill HC Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375 [TBL] [Abstract][Full Text] [Related]
6. CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation. Keller CW; Kotur MB; Mundt S; Dokalis N; Ligeon LA; Shah AM; Prinz M; Becher B; Münz C; Lünemann JD Autophagy; 2021 May; 17(5):1244-1258. PubMed ID: 32401602 [TBL] [Abstract][Full Text] [Related]
7. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells. Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682 [TBL] [Abstract][Full Text] [Related]
8. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway. Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419 [TBL] [Abstract][Full Text] [Related]
9. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis. Parker Harp CR; Archambault AS; Sim J; Ferris ST; Mikesell RJ; Koni PA; Shimoda M; Linington C; Russell JH; Wu GF J Immunol; 2015 Jun; 194(11):5077-84. PubMed ID: 25895531 [TBL] [Abstract][Full Text] [Related]
10. The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity. Xu Y; Zhao F; Qiu Q; Chen K; Wei J; Kong Q; Gao B; Melo-Cardenas J; Zhang B; Zhang J; Song J; Zhang DD; Zhang J; Fan Y; Li H; Fang D Nat Commun; 2016 Jul; 7():12073. PubMed ID: 27417417 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness. Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells. Cho KJ; Walseng E; Ishido S; Roche PA Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324 [TBL] [Abstract][Full Text] [Related]
13. MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells. Oh J; Perry JSA; Pua H; Irgens-Möller N; Ishido S; Hsieh CS; Shin JS J Cell Biol; 2018 Apr; 217(4):1395-1410. PubMed ID: 29371232 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4 Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505 [TBL] [Abstract][Full Text] [Related]
16. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells. Cho KJ; Ishido S; Eisenlohr LC; Roche PA J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461 [TBL] [Abstract][Full Text] [Related]
17. Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice. Lucca LE; Axisa PP; Aloulou M; Perals C; Ramadan A; Rufas P; Kyewski B; Derbinski J; Fazilleau N; Mars LT; Liblau RS Eur J Immunol; 2016 Sep; 46(9):2247-59. PubMed ID: 27334749 [TBL] [Abstract][Full Text] [Related]
18. Altered MARCH1 ubiquination-regulated dendritic cell immune functions during the early stage of zymosan-induced multiple organ dysfunction syndrome (MODS) in mice. Li F; Lu JY; Liu Q; Wang HW; Guo H Immunol Lett; 2013 Feb; 150(1-2):105-15. PubMed ID: 23305794 [TBL] [Abstract][Full Text] [Related]
19. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]